Right ventricular injury increases mortality in patients with acute respiratory distress syndrome on veno-venous extracorporeal membrane oxygenation: A systematic review and meta-analysis
dc.contributor.author | Chad, Thomas | |
dc.contributor.author | Yusuff, Hakeem | |
dc.contributor.author | Zochios, Vasileios | |
dc.date.accessioned | 2023-05-12T15:29:53Z | |
dc.date.available | 2023-05-12T15:29:53Z | |
dc.date.issued | 2023-01 | |
dc.identifier.citation | Chad, T., Yusuff, H., Zochios, V., Pettenuzzo, T., Fan, E., Schmidt, M., & Protecting the Right Ventricle network (PRORVnet) (2023). Right Ventricular Injury Increases Mortality in Patients With Acute Respiratory Distress Syndrome on Veno-Venous Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis. ASAIO journal (American Society for Artificial Internal Organs : 1992), 69(1), e14–e22. https://doi.org/10.1097/MAT.0000000000001854 | en_US |
dc.identifier.other | 10.1097/mat.0000000000001854 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12904/16985 | |
dc.description.abstract | Right ventricular injury (RVI) in the context of acute respiratory distress syndrome (ARDS) is well recognized as an important determinant risk factor of mortality. Veno-venous extracorporeal membrane oxygenation (VV-ECMO) is part of the algorithm for the management of patients with severe ARDS and severely impaired gas exchange. Although VV-ECMO may theoretically protect the RV it is uncertain to what degree RVI persists despite VV-ECMO support, and whether it continues to influence mortality after ECMO initiation. The aim of this systematic review and meta-analysis was to investigate the impact of RVI on mortality in this context, testing the hypothesis that RVI worsens mortality in this cohort. We performed a systematic search that identified seven studies commenting on RVI and mortality in patients with ARDS receiving VV-ECMO. The presence of RVI was associated with greater mortality overall (odds ratios [OR]: 2.72; 95% confidence intervals [CI]: 1.52-4.85; p < 0.00) and across three subgroups (RV dilatational measures: OR: 3.51; 95% CI: 1.51-8.14; p < 0.01, RV functional measures: OR: 1.84; 95% CI: 0.99-3.42; p = 0.05, RV measurements post-ECMO initiation: OR: 1.94; 95% CI: 1.01-3.72; p < 0.05). Prospective studies are needed to investigate the causal relationship between RVI and mortality in this patient group and the best management strategies to reduce mortality. | |
dc.description.uri | https://journals.lww.com/asaiojournal/Abstract/2023/01000/Right_Ventricular_Injury_Increases_Mortality_in.6.aspx | en_US |
dc.language.iso | en | en_US |
dc.title | Right ventricular injury increases mortality in patients with acute respiratory distress syndrome on veno-venous extracorporeal membrane oxygenation: A systematic review and meta-analysis | en_US |
dc.type | Article | en_US |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |
rioxxterms.version | NA | en_US |
rioxxterms.versionofrecord | https://doi.org/10.1097/MAT.0000000000001854 | en_US |
rioxxterms.type | Journal Article/Review | en_US |
refterms.panel | Unspecified | en_US |
html.description.abstract | Right ventricular injury (RVI) in the context of acute respiratory distress syndrome (ARDS) is well recognized as an important determinant risk factor of mortality. Veno-venous extracorporeal membrane oxygenation (VV-ECMO) is part of the algorithm for the management of patients with severe ARDS and severely impaired gas exchange. Although VV-ECMO may theoretically protect the RV it is uncertain to what degree RVI persists despite VV-ECMO support, and whether it continues to influence mortality after ECMO initiation. The aim of this systematic review and meta-analysis was to investigate the impact of RVI on mortality in this context, testing the hypothesis that RVI worsens mortality in this cohort. We performed a systematic search that identified seven studies commenting on RVI and mortality in patients with ARDS receiving VV-ECMO. The presence of RVI was associated with greater mortality overall (odds ratios [OR]: 2.72; 95% confidence intervals [CI]: 1.52-4.85; p < 0.00) and across three subgroups (RV dilatational measures: OR: 3.51; 95% CI: 1.51-8.14; p < 0.01, RV functional measures: OR: 1.84; 95% CI: 0.99-3.42; p = 0.05, RV measurements post-ECMO initiation: OR: 1.94; 95% CI: 1.01-3.72; p < 0.05). Prospective studies are needed to investigate the causal relationship between RVI and mortality in this patient group and the best management strategies to reduce mortality. | en_US |
rioxxterms.funder.project | 94a427429a5bcfef7dd04c33360d80cd | en_US |